SCARPA, ROBERTO MARIO
 Distribuzione geografica
Continente #
AS - Asia 7.235
NA - Nord America 5.491
EU - Europa 1.665
SA - Sud America 922
AF - Africa 103
Continente sconosciuto - Info sul continente non disponibili 75
OC - Oceania 28
AN - Antartide 1
Totale 15.520
Nazione #
US - Stati Uniti d'America 5.207
SG - Singapore 4.141
CN - Cina 1.267
HK - Hong Kong 896
IT - Italia 855
BR - Brasile 655
VN - Vietnam 371
GB - Regno Unito 235
FR - Francia 224
BD - Bangladesh 183
CA - Canada 127
DE - Germania 122
AR - Argentina 103
IN - India 98
EC - Ecuador 65
ID - Indonesia 59
MX - Messico 54
NL - Olanda 47
TR - Turchia 38
CO - Colombia 33
UA - Ucraina 30
RU - Federazione Russa 29
ZA - Sudafrica 28
IQ - Iraq 23
AU - Australia 22
ES - Italia 21
PH - Filippine 18
PL - Polonia 18
CR - Costa Rica 17
IR - Iran 17
PK - Pakistan 17
FI - Finlandia 16
EG - Egitto 15
PY - Paraguay 15
VE - Venezuela 15
GT - Guatemala 14
MA - Marocco 14
CL - Cile 13
JP - Giappone 13
SA - Arabia Saudita 13
JM - Giamaica 12
EE - Estonia 11
MY - Malesia 11
NI - Nicaragua 11
TN - Tunisia 11
HN - Honduras 10
MD - Moldavia 10
NP - Nepal 10
PE - Perù 10
TH - Thailandia 10
CW - ???statistics.table.value.countryCode.CW??? 9
KE - Kenya 9
SV - El Salvador 9
TT - Trinidad e Tobago 8
DK - Danimarca 7
JO - Giordania 7
SE - Svezia 7
DO - Repubblica Dominicana 6
IE - Irlanda 6
UY - Uruguay 6
BO - Bolivia 5
CZ - Repubblica Ceca 5
KZ - Kazakistan 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
DZ - Algeria 4
GP - Guadalupe 4
IL - Israele 4
KR - Corea 4
LB - Libano 4
TW - Taiwan 4
BE - Belgio 3
BH - Bahrain 3
PR - Porto Rico 3
RO - Romania 3
UZ - Uzbekistan 3
AL - Albania 2
BS - Bahamas 2
BW - Botswana 2
CG - Congo 2
CI - Costa d'Avorio 2
CY - Cipro 2
KG - Kirghizistan 2
KH - Cambogia 2
LC - Santa Lucia 2
LY - Libia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PA - Panama 2
SN - Senegal 2
TZ - Tanzania 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BY - Bielorussia 1
CH - Svizzera 1
CM - Camerun 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
Totale 15.429
Città #
Ashburn 1.173
San Jose 1.143
Hong Kong 882
Singapore 756
Dallas 677
Rome 531
Hefei 433
Beijing 295
Council Bluffs 254
Columbus 221
Boardman 214
London 192
Lauterbourg 191
Ho Chi Minh City 137
Shanghai 123
Phoenix 92
Santa Clara 90
Hanoi 81
Los Angeles 67
New York 65
São Paulo 47
Toronto 43
San Francisco 42
Mexico City 36
Frankfurt am Main 33
Seattle 32
Milan 29
Rio de Janeiro 29
Naples 28
Pune 27
Atlanta 26
Guayaquil 25
Chicago 24
Munich 23
Washington 23
Amsterdam 19
Brooklyn 17
Chennai 17
Montreal 17
Boston 15
Haiphong 15
Miami 15
Quito 15
Las Vegas 14
Warsaw 14
Xi'an 13
Belo Horizonte 12
Biên Hòa 12
Brasília 12
Denver 12
Porto Alegre 12
Curitiba 11
Managua 11
San José 11
Buffalo 10
Johannesburg 10
Manaus 10
Thái Bình 10
Tokyo 10
Bologna 9
Campinas 9
Charlotte 9
Florence 9
Guangzhou 9
Guatemala City 9
Lahore 9
Nuremberg 9
Sydney 9
Willemstad 9
Da Nang 8
Dhaka 8
East Orange 8
Jakarta 8
Lima 8
Nairobi 8
Orem 8
Turku 8
Amman 7
Bacoor 7
Bogotá 7
Joinville 7
Melbourne 7
Mumbai 7
Salvador 7
The Bronx 7
Tunis 7
Andover 6
Buenos Aires 6
Cairo 6
Can Tho 6
Catania 6
Formosa 6
Fortaleza 6
Hangzhou 6
Helsinki 6
Houston 6
Kingston 6
Montevideo 6
Newark 6
Ninh Bình 6
Totale 8.699
Nome #
Robotic Medtronic Hugo™ RAS System Is Now Reality: Introduction to a New Simulation Platform for Training Residents 309
[-2]proPSA versus ultrasensitive PSA fluctuations over time in the first year from radical prostatectomy, in an high-risk prostate cancer population: A first report 265
Prevalence and potential predictors of incidental prostate Cancer in patients undergoing surgery for Benign Prostatic obstruction: a retrospective study in the MRI era 241
Background to and management of treatment-related bone loss in prostate cancer. 231
Is a Course of Intermittent Self-dilatation with Topical Corticosteroids Superior at Stabilising Urethral Stricture Disease in Men and Improving Functional Outcomes over a Course of Intermittent Self-dilatation Alone? A Systematic Review and Meta-analysis 230
Biopsy and radical prostatectomy pathological patterns influence Prostate cancer gene 3 (PCA3) score 225
Adreno-cortical cancer: open or laparoscopic surgery? 217
Urologic surgery in a safe hospital during the COVID-19 pandemic scenario 207
Applications of augmented reality in urology: expanding its potentials and fields of usage 206
The role of multiparametric magnetic resonance imaging in the diagnosis of local recurrence after radical prostatectomy and before salvage radiotherapy 196
Comparison between Three Radiomics Models and Clinical Nomograms for Prediction of Lymph Node Involvement in PCa Patients Combining Clinical and Radiomic Features 177
A magnetic endourethral sphincter against stress urinary incontinence: preliminary pilot study in humans 174
Health-related quality of life in patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitors. the role of combination treatment therapy 173
[Prostatite asintomatica: Una frequente causa di elevazione del PSA [Asymptomatic prostatitis: a frequent cause of raising PSA] 169
The fight between PCNL, laparoscopic and robotic pyelolithotomy: do we have a winner? A systematic review and meta-analysis 151
How Can the COVID-19 Pandemic Lead to Positive Changes in Urology Residency? 144
Bioethical implications of robotic surgery in urology: a systematic review 140
Accuracy of magnetic resonance imaging to identify pseudocapsule invasion in renal tumors 132
A second cycle of tamsulosin in patients with distal ureteric stones: a prospective randomized trial 131
Assessment of surgical margins in renal cell carcinoma after nephron sparing: a comparative study: laparoscopy vs open surgery 130
ASSESSMENT OF RENAL DAMAGE FOLLOWING WARM ISCHEMIA TIME DURING LPN: RESULTS OF A PROSPECTIVE STUDY 130
Assessment of Risk Factors for Complications of Laparoscopic Partial Nephrectomy 127
Assessment of renal damage following warm ischemia time during LPN: results of a prospective study 127
Bladder perforation during transurethral resection of the bladder: a comprehensive algorithm for diagnosis, management and follow-up 125
Biological glues and collagen fleece for hemostasis during laparoscopic partial nephrectomy: techniques and result of a prospective study 125
"Δ" Delta neobladder: a novel stentless simplified totally intracorporeal robotic technique 125
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 121
Impact of Robotic Technologies on Prostate Cancer Patients’ Choice for Radical Treatment 114
Analysis of complications in a laparoscopic urological centre: Trend and experience of a single surgeon after 1100 procedures 112
Current management of radiation cystitis after pelvic radiotherapy: a systematic review 110
Biomarkers for Renal Cell Carcinoma Recurrence: State of the Art 109
Are Urologists Ready for Interpretation of Multiparametric MRI Findings? A Prospective Multicentric Evaluation 109
Laparoscopic versus Ultrasound-Guided Transversus Abdominis Plane Block for Postoperative Analgesia Management after Radical Prostatectomy: Results from a Single Center Study 100
Urinary Continence Restoration Through an Endourethral Device: A 3-Month Pilot Study on 10 Patients 97
Corticosteroids and tamsulosin in the medical expulsive therapy for symptomatic distal ureter stones: single drug or association? 96
A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project 95
Robot-Assisted Renal Surgery with the New Hugo Ras System: Trocar Placement and Docking Settings 94
Video-Assisted Informed Consent in Endoscopic Urology: A Randomized Trial on Ureteroscopy 84
The number of lymph nodes examined and staging accuracy in renal cell carcinoma. 84
Reassessing the current TNM lymph node staging for renal cell carcinoma 82
Surgical Outcomes of Hugo™ RAS Robot-Assisted Partial Nephrectomy for Cystic Renal Masses: Technique and Initial Experience 81
Psychological distress in men with prostate cancer receiving adjuvant androgen-deprivation therapy. 80
Radiomic Machine-Learning Analysis of Multiparametric Magnetic Resonance Imaging in the Diagnosis of Clinically Significant Prostate Cancer: New Combination of Textural and Clinical Features 79
Video Consensus and Radical Prostatectomy: The Way to Chase the Future? 77
Early ligature of renal artery during radical laparoscopic transperitoneal nephrectomy: description of standard technique and direct access 76
Hugo TM RAS vs Da Vinci® Xi Robot-Assisted Partial Nephrectomy: First Propensity Score-Matched Comparison of Perioperative and Functional Outcomes 75
Robot-assisted partial nephrectomy using the novel Hugo™ RAS system: Feasibility, setting and perioperative outcomes of the first off-clamp series 74
Is renal warm ischemia over 30 minutes during laparoscopic partial nephrectomy possible? One-yer results of a prospective study 74
Real-Time Urethral and Ureteral Assessment during Radical Cystectomy Using Ex-Vivo Optical Imaging: A Novel Technique for the Evaluation of Fresh Unfixed Surgical Margins 73
The impact of sars-cov-2 pandemic on time to primary, secondary resection and adjuvant intravesical therapy in patients with high-risk non-muscle invasive bladder cancer: A retrospective multi-institutional cohort analysis 72
State of the Art in Robotic Surgery with Hugo RAS System: Feasibility, Safety and Clinical Applications 72
Scarpa RM, Papalia R. Re: Giusti et al., Editorial Comment on: Supracostal Upper Pole Endoscopic-Guided Prone Tubeless "Maxi-Percutaneous Nephrolithotomy": A Contemporary Evaluation of Complications by Altschuler et al. (From: Giusti G, Proietti S, and Rodríguez-Socarrás, ME. J Endourol 2019;33:279-280; DOI: 10.1089/end.2018.0856). J Endourol. 2019 Apr;33(4):281-282. doi: 10.1089/end.2019.0005. Epub 2019 Mar 26. PMID: 30760023. 72
THE ONSET OF SKELETAL COMPLICATIONS IN HORMONEREFRACTORY PROSTATE CANCER PATIENTS IS NOT INFLUENCEDBY THE DURATION OF ANDROGEN DEPRIVATION THERAPY 72
Role of PSA levels and pathological stadiation before radiation therapy in predicting mp-MRI results in patients with prostate cancer recurrence after radical prostatectomy 71
Urinary Tract Infection Predictors in Patients Undergoing Retrograde IntraRenal Surgery for Renal Stones: Does the Instrument Make the Difference? 71
Supra-ampullar cystectomy with preservation of sexual function and ileal orthotopic reservoir for bladder tumor: twenty years of experience 71
Feasibility of 21-day continuous infusion of epirubicin in hormone-refractory prostate cancer patients 70
Triggers for delayed intervention in patients with small renal masses undergoing active surveillance: A systematic review 69
PSA decrease after levofloxacin therapy in patients with histological prostatitis 69
Direct access to the renal artery at the level of treitz ligament during left radical laparoscopic transperitoneal nephrectomy 68
Selective versus Standard Ligature of the Deep Venous Complex during Laparoscopic Radical Prostatectomy: Effects on Continence, Blood Loss, and Margin Status 68
CORRELATION BETWEEN PERIPROSTATIC NERVES ANATOMY AND POTENCY IN PATIENTS UNDERGONE EXTRAPERITONEOSCOPIC RADICAL PROSTATECTOMY 68
Variazione nel tempo di incidenza e significato predittivo (di carcinoma in successive biopsie) del riscontro di "PIN" e "ASAP" in mapping prostatici dal 1995 al 2006. 68
Surgical margin status of specimen and oncological outcomes after laparoscopic radical prostatectomy: experience after 400 procedures. 68
Exploring the Residents’ Perspective on Smart learning Modalities and Contents for Virtual Urology Education: Lesson Learned During the COVID-19 Pandemic 67
Laparoscopic adrenalectomy for malignancy 67
Extraperitoneoscopic transcapsular adenomectomy: complications and functional results after at least 1 year of followup. 67
Potential prognostic value of miRNAs as biomarker for progression and recurrence after nephrectomy in renal cell carcinoma: a literature review 67
Positron emission tomography as a tool for the "tailored" management of retroperitoneal fibrosis: a nephro-urological experience 66
Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease 66
Role of adjunctive medical therapy with nifedipine and deflazacort after extracorporeal shock wave lithotripsy of ureteral stones. 66
Laparoscopic dismembered pyeloplasty for right retrocaval ureter 66
Mini-retroperitoneoscopic adrenalectomy: our experience after 50 procedures 66
Role of fluorescence confocal microscopy for rapid evaluation of EUS fine-needle biopsy sampling in pancreatic solid lesions 65
Transcapsular adenomectomy (Millin): a comparative study, extraperitoneal laparoscopy versus open surgery 65
Second cycle of medical expulsive therapy with tamsulosin in patients non responders to a first cycle for distal ureteral stones: Results of a prospective randomised trial 65
Changes in prostatic cancer at radical prostatectomy during the prostate specific antigen era: an Italian experience 65
Supra-ampullar cystectomy and ileal neobladder 65
SIMULTANEOUS IMPLANTATION OF BONE ANCHORED SLING AND INFLATABLE PENILE PROSTHESIS THROUGH A SINGLE PENO-SCROTAL INCISION 65
Predictors of Urinary Continence Recovery after Laparoscopic-Assisted Radical Prostatectomy: Is Surgical Urethral Length the Only Key Factor? 64
Skill Transfer from Laparoscopic Partial Nephrectomy to the Hugo™ RAS System: A Novel Proficiency Score to Assess Surgical Quality during the Learning Curve 64
The Patrick-FABER test in detecting active sacroiliitis in spondyloarthritis patients: a prospective study using magnetic resonance as reference standard 64
Proposal of an improved prognostic classification for pT3 renal cell carcinoma 63
Significato prognostico dell'attuale stadiazione linfonodale del carcinoma renale 63
Transperitoneal left laparoscopic pyeloplasty with transmsocolic access to the pelvi-ureteric junction: technique description and results with a minimum follow up of 1 year 63
Impact of a delayed presentation to the emergency department for acute renal colic on biochemical and clinical outcomes 62
Y-neobladder: an easy, fast, and reliable procedure 62
Sequential transurethral resection of the prostate and laparoscopic bladder diverticulectomy: comparison with open surgery. 62
Extraperitoneoscopic Millin transcapsular prostatic adenomectomy 62
Does mass size really affect safety and effectiveness of laparoscopic adrenalectomy? 62
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting 62
Laparosopic transcapsular simple prostatectomy millin: Our experience after 50 cases 61
Is laparoscopic bladder diverticulectomy after transurethral resection of the prostate safe and effective? Comparison with open surgery 61
Home and office uroflowmetry for evaluation of LUTS from benign prostatic enlargement 61
Prostate cancer gene 3 urine assay cutoff in diagnosis of prostate cancer: a validation study on an Italian patient population undergoing first and repeat biopsy 61
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 61
Implementation and strategies to ensure adequate coordination within a Urology Department during the COVID-19 pandemic 61
Laparoscopic vesico-vaginal fistula repair: our experience and review of the literature 60
Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease 60
Left transperitoneal laparoscopic pyeloplasty with direct access to the ureteropelvic junction: Description of the technique and results with 1 year minimum follow up 60
Totale 10.039
Categoria #
all - tutte 103.244
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.244


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022235 0 0 0 2 4 0 0 2 9 12 4 202
2022/202377 1 3 3 6 4 1 18 2 4 0 32 3
2023/2024541 14 81 17 48 53 253 10 23 8 9 15 10
2024/20255.024 92 67 214 23 39 149 208 47 529 459 1.418 1.779
2025/20267.675 540 231 1.118 1.102 215 368 1.622 535 654 673 407 210
2026/20271.966 112 609 563 682 0 0 0 0 0 0 0 0
Totale 15.520